Accounts Payable, Current of Cyclo Therapeutics, Inc. from 31 Dec 2022 to 30 Sep 2024

Taxonomy & unit: us-gaap: USD
Description: Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary: Cyclo Therapeutics, Inc. quarterly Accounts Payable, Current in USD history and change rate from 31 Dec 2022 to 30 Sep 2024.
Cyclo Therapeutics, Inc. Accounts Payable, Current for the quarter ending 30 Sep 2024 was $5,023,095.
Source SEC data: View on sec.gov

Accounts Payable, Current, Quarterly (USD)

Accounts Payable, Current, YoY Quarterly Change (%)

Cyclo Therapeutics, Inc. Quarterly Accounts Payable, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2024	$5,023,095			30 Sep 2024	10-Q	14 Nov 2024	2024	Q3
Q2 2024	$3,859,822			30 Jun 2024	10-Q	14 Aug 2024	2024	Q2
Q1 2024	$3,670,646			31 Mar 2024	10-Q	15 May 2024	2024	Q1
Q4 2023	$4,856,530	+$2,622,636	+117%	31 Dec 2023	10-K/A	18 Dec 2024	2024	FY
Q4 2022	$2,233,894			31 Dec 2022	10-K/A	18 Dec 2024	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.